Home / Research library / Tesamorelin / Ipamorelin
Tesamorelin / Ipamorelin: molecular data, studies & sources
Tesamorelin / Ipamorelin is catalogued here as a combination of ingredients. This profile brings together the molecular source record, selected indexed publications and available supplier comparisons. Evidence for a named substance does not authenticate a commercial product.
Compiled by PeptideTech Editors · Sources checked · Selected bibliography, not a systematic review
Molecular formula, weight & structure
A blend is not one molecule
This is a combination of separate ingredients, not a single molecule. Ingredient molecular weights cannot be added to describe a vial or establish evidence for the blend.
MF: not assigned · MW: not assigned · Structure: not assigned
Catalogued ingredients: Tesamorelin · Ipamorelin. The supplier must specify the amount and identity of each ingredient.
Registered clinical trials
Studies registered on ClinicalTrials.gov that list Tesamorelin / Ipamorelin as an intervention. Studies that only measure the molecule as a biomarker, or use it only as a comparator or background arm for another drug, are excluded. A registration describes a planned or completed protocol; it does not report a result. Active studies are listed first.
This combination is not registered as a single studied intervention. Registered trials of individual ingredients are listed on their own profiles.
Human intervention studies
Selected studies in which participants received Tesamorelin / Ipamorelin, with their indexed or reviewed study type. Check the original article for the formulation, population and controls. Studies that only measured the molecule, or used it as a comparator, are listed separately below and are not counted as intervention studies.
No human study that administered this compound was retained in this selected bibliography. This is a documented evidence gap in our selection, not proof that no study exists.
Preclinical research, reviews & other publications
Animal studies, laboratory experiments, reviews and other indexed papers answer different questions. A review is secondary evidence; a case report does not estimate how often an outcome occurs.
No additional matching publication was retained. The search links below allow further investigation; they are not evidence that a study exists.
Tesamorelin / Ipamorelin supplier sources
Scientific sources describe molecules and experiments. The commercial links below identify recorded supplier packages. A publication or chemical database entry does not verify the seller, purity, sterility or contents of a lot. Some links are affiliate links; see our disclosure.
Tesamorelin / Ipamorelin for sale: compare prices, sizes and forms from every tracked supplier →
| Supplier | Recorded packages | Example source listing |
|---|---|---|
| Amino USAUSD | 6/2mg Vial1 recorded offers | 6/2mg Vial · $90.00Checked Nov 6, 2026Supplier listing, Tesamorelin / Ipamorelin 6/2mg Vial, Amino USA, opens in a new tab |
| Cenexa LabsUSD | 10/5mg Vial1 recorded offers | 10/5mg Vial · $114.99Recorded out of stock · Checked Nov 6, 2026Supplier listing, Tesamorelin / Ipamorelin 10/5mg Vial, Cenexa Labs, opens in a new tab |
| American PeptidesUSD | 10/5mg Vial1 recorded offers | 10/5mg Vial · $140.00Stale observation · Checked Oct 21, 2026Supplier listing, Tesamorelin / Ipamorelin 10/5mg Vial, American Peptides, opens in a new tab |
Reference sources & further reading
The citations above link directly to publication records. Encyclopedia links are background reading and are not used to establish clinical effectiveness.
Search for additional research
These links run searches; their results have not been individually reviewed and can include unrelated compounds.
Research information is not a dosing guide or a recommendation for personal use. Study findings are specific to the formulation, population and methods tested. Read our source and correction policy.
Ingredient and related research
Ipamorelin
C38H49N9O5
711.9 g/mol · PubChem CID 9831659
3 selected publications · 2 human intervention studies · 2 registered trials
Protein / peptide · highest stage: Phase 2
Tesamorelin
C221H366N72O67S
5136 g/mol · PubChem CID 16137828
7 selected publications · 7 human intervention studies · 20 registered trials
US: active ingredient of an FDA-approved medicine · Drugs@FDA
Protein / peptide · highest stage: Approved in at least one jurisdiction (ChEMBL phase 4)